BRBurt Richards

Burt Richards

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Burt Richards has a total of 84 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Role of Erythropoietin Receptor Signaling in Macrophages or Choroidal Endothelial Cells in Choroidal Neovascularization

    by Aniket Ramshekar, Colin A. Bretz, Eric Kunz, Thaonhi Cung, Burt T. Richards, Gregory J. Stoddard, Gregory S. Hageman, Brahim Chaqour, M. Elizabeth Hartnett

    Erythropoietin (EPO) has been proposed to reduce the progression of atrophic age-related macular degeneration (AMD) due to its potential role in neuroprotection. However, overactive EPO receptor (EPOR) signaling increased laser-induced choroidal neovascularization (CNV) and choroidal macrophage number in non-lasered mice, which raised the question of whether EPOR signaling increased CNV through the recruitment of macrophages to the choroid that released pro-angiogenic factors or through direct angiogenic effects on endothelial cells. In this study, we addressed the hypothesis that EPOR signaling increased CNV by direct effects on macrophages or endothelial cells. We used tamoxifen-inducible macrophage-specific or endothelial cell-specific EPOR knockout mice in the laser-induced CNV model, and cultured choroidal endothelial cells isolated from adult human donors. We found that macrophage-specific knockout of EPOR influenced laser-induced CNV in females only, whereas endothelial-specific knockout of EPOR reduced laser-induced CNV in male mice only. In cultured human choroidal endothelial cells, knockdown of EPOR reduced EPO-induced signal transducer and activator of transcription 3 (STAT3) activation. Taken together, our findings suggest that EPOR signaling in macrophages or choroidal endothelial cells regulates the development of CNV in a sex-dependent manner. Further studies regarding the role of EPO-induced signaling are required to assess EPO safety and to select or develop appropriate therapeutic approaches.


  • Open Access

    Chromosome 10q26–driven age-related macular degeneration is associated with reduced levels of HTRA1 in human retinal pigment epithelium

    by Brandi L Williams, Nathan A Seager, Jamie D Gardiner, Chris M Pappas, Monica C Cronin, Cristina Amat di San Filippo, Robert A Anstadt, Jin Liu, Marc A Toso, Lisa Nichols, et al.

    Significance: The chromosome 10q26 locus is the genetic region most strongly associated with elevated risk of age-related macular degeneration (AMD), but the underlying genetic defects initiating disease are unresolved. Using human-derived eye tissues, we demonstrate that mRNA encoding the serine protease, HTRA1, is reduced in the retinal pigment epithelium (RPE) of donors with risk-associated variants that disrupt a cis-regulatory element within the 10q26 locus. Consequentially, there is diminished HtrA1 protein within the RPE–Bruch’s membrane interface, the primary site of AMD initiation, with age. This indicates that HtrA1 functions to maintain the integrity of this interface during the aging process and that HtrA1 levels are impaired by chromosome 10q26 risk-associated variants. HtrA1 augmentation may be a viable therapeutic option for AMD.


  • Open Access

    Author Correction: Macular retinal thickness differs markedly in age-related macular degeneration driven by risk polymorphisms on chromosomes 1 and 10

    by Moussa A. Zouache, Alex Bennion, Jill L. Hageman, Christian Pappas, Burt T. Richards, Gregory S. Hageman

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.


  • Discovery and SAR of Methylated Tetrahydropyranyl Derivatives as Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase (ICMT)

    by Weston R. Judd, Paul M. Slattum, Khanh C. Hoang, Leena Bhoite, Liisa Valppu, Glen Alberts, Brita Brown, Bruce Roth, Kirill Ostanin, Liwen Huang, et al.

    A series of tetrahydropyranyl (THP) derivatives has been developed as potent inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT) for use as anticancer agents. Structural modification of the submicromolar hit compound 3 led to the potent 3-methoxy substituted analogue 27. Further SAR development around the THP ring resulted in an additional 10-fold increase in potency, exemplified by analogue 75 with an IC50 of 1.3 nM. Active and potent compounds demonstrated a dose-dependent increase in Ras cytosolic protein. Potent ICMT inhibitors also reduced cell viability in several cancer cell lines with growth inhibition (GI50) values ranging from 0.3 to >100 μM. However, none of the cellular effects observed using ICMT inhibitors were as pronounced as those resulting from a farnesyltransferase inhibitor.


  • 2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97)

    by Matthew G. Bursavich, Daniel P. Parker, J. Adam Willardsen, Zhong-Hua Gao, Thaylon Davis, Kirill Ostanin, Rosann Robinson, Ashley Peterson, Daniel M. Cimbora, Ju-Fen Zhu, et al.


  • Open Access

    Marine Natural Product Libraries for High-Throughput Screening and Rapid Drug Discovery

    by Tim S. Bugni, Burt Richards, Leen Bhoite, Daniel Cimbora, Mary Kay Harper, Chris M. Ireland

    There is a need for diverse molecular libraries for phenotype-selective and high-throughput screening. To make marine natural products (MNPs) more amenable to newer screening paradigms and shorten discovery time lines, we have created an MNP library characterized online using MS. To test the potential of the library, we screened a subset of the library in a phenotype-selective screen to identify compounds that inhibited the growth of BRCA2-deficient cells.


  • Stable expression of Anthozoa fluorescent proteins in mammalian cells

    by Burt Richards, Ludmilla Zharkikh, Forrest Hsu, Christine Dunn, Alexander Kamb, David H.‐F. Teng

    Background Fluorescent proteins have become invaluable reporters in many areas of cellular and developmental biology. An enhanced version of the Aequorea victoria green fluorescent protein (AvEGFP) is the most widely used fluorescent protein. For a variety of reasons, it is useful to have alternative fluorescent proteins to AvEGFP. Methods The cDNA sequences for enhanced variants of the Anemonia cyan fluorescent protein (AmCyan1), as well as the Zoanthus green (ZsGreen1) and yellow (ZsYellow1) fluorescent proteins, were cloned downstream of a constitutive cytomegalovirus (CMV) promoter within a retroviral expression vector. NIH3T3, HEK293, SW620, and WM35 cells were transduced with recombinant retroviruses at a low multiplicity of infection (MOI) to bias for single‐copy integration. Both unselected and stably selected cells transduced with the retroviral expression constructs were characterized. Expression of each fluorescent protein in cells was detected using flow cytometry and fluorescence microscopy with filter sets typically used for AvEGFP/fluorescein isothiocyanate (FITC) detection and was compared with the expression of AvEGFP. In addition, a fluorescence plate reader with several excitation and emission filter sets was used for detection. Results Expression of each protein was observable by fluorescence microscopy. Under given conditions of flow cytometry, the ZsGreen1 mean fluorescence was approximately 3‐fold, 10‐fold, and 50‐fold greater than that of AvEGFP, ZsYellow1, and AmCyan1, respectively. AmCyan1, ZsGreen1, and AvEGFP were detected by a fluorescence plate reader. Conclusion We determined that fluorescent proteins from Anthozoa species are detectable using a standard flow cytometer and fluorescence microscope. All of the mammalian cell lines tested expressed detectable levels of fluorescent proteins from stable integrated provirus. In cell lines where the AvEGFP protein is toxic or poorly expressed, these Anthozoa fluorescent proteins may serve as alternative fluorescent reporters. Cytometry 48:106–112, 2002.


  • Open Access

    Exogenous Peptide and Protein Expression Levels Using Retroviral Vectors in Human Cells

    by Tanya M. Sandrock, Bob Risley, Burt T. Richards, Mark A. Poritz, Harry A. Austin, Sanghee Yoo, Marianne K.-H. Kim, Bruce Roth, Karen Repetny, Forrest Hsu, et al.


  • Open Access

    Enrichment during transdominant genetic experiments using a flow sorter

    by Robert Sandrock, Jon Karpilow, Burt Richards, Andrew Maxfield, Chunwei Wang, Robert Risley, Mathew Rebentisch, Beth Drees, David H.-F. Teng, Giordano Caponigro, et al.


    • 1 July 1999
      • Vol. 59  (13) , 3021-7

    Apoptosis induced by overexpression of hMSH2 or hMLH1.

    by H Zhang, B Richards, T Wilson, M Lloyd, A Cranston, A Thorburn, R Fishel, M Meuth

    Mutations of the mismatch repair genes hMSH2 and hMLH1 have been found in a high proportion of individuals with hereditary nonpolyposis colon cancer (HNPCC), establishing the link between mismatch repair and cancer. Tumor cell lines that are deficient in mismatch repair develop a mutator phenotype that appears to drive the accumulation of mutations required for tumor development. However, mutations of other mismatch repair genes such as hPMS2 can lead to a mutator phenotype, although inherited mutations of these genes are rare in HNPCC families. Here, we show that overexpression of hMSH2 or hMLH1 but not of hMSH3, hMSH6, or hPMS2 induces apoptosis in either repair-proficient or -deficient cells. Furthermore, primary mouse embryo fibroblasts derived from Msh2-deficient mice lose their ability to undergo apoptosis after treatment with N-methyl-N'-nitro-N-nitrosoguanidine. These results suggest that the mismatch repair proteins hMSH2 and hMLH1 may be components of a pathway that influences apoptosis. We consider the possibility that loss of apoptosis as a result of hMSH2 or hMLH1 deficiency may be an additional factor in cancer predisposition in HNPCC.